Syed Shah
Ophthalmology · la Crosse, WINPI 1932348034
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,600 of the $16,392 with a category attached, or 89.1%. Bausch & Lomb Americas Inc. accounts for 76.6% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $12,549, 3.4 times the $3,726 reported in 2020. Among ophthalmology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 13 payments — averaging $1260.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$13K
- Janssen Global Services, LLC$4K
- Alimera Sciences, Inc.$126
- Mallinckrodt Hospital Products Inc.$100
- Apellis Pharmaceuticals, Inc.$17
Across 1 payment — averaging $9000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$9K
What the payments were for
- Consulting fees$14,60089%
- Travel & lodging$1,4459%
- Food & beverage$3302%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 9 | $12,549 |
| Janssen Global Services, LLC | 1 | $3,600 |
| Alimera Sciences, Inc. | 1 | $126 |
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
| Apellis Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS ELITE$11,000
- Iluvien$126
How this compares
$16,392 in reported general payments places this provider in the 95th percentile of 337 ophthalmology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 381 | $20,092 |
| Ketorolac Tromethamine | 348 | $9,087 |
| Ofloxacin | 220 | $2,158 |
| Brimonidine Tartrate | 42 | $1,954 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 52 | $859 |
| Atropine Sulfate | 28 | $843 |
| ErythromycinErythromycin Base | 34 | $362 |
| Latanoprost | 30 | $340 |
| MoxifloxacinMoxifloxacin Hcl | 16 | $279 |
| Timolol Maleate | 18 | $100 |
| Acetazolamide ErAcetazolamide | 14 | $96 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in la Crosse
- Cindy Calderonla Crosse$3K
- Inder SinghRacine$2.5M
- Deepak SambharaWausau$388K
- John VukichWauwatosa$356K
- Eugene EldridgeKenosha$294K
- Michael ShapiroMadison$71K
- Douglas SalmAppleton$38K
- Julia AgapovMadison$26K
- Thomas HarveyChippewa Falls$23K
- Michael VrabecAppleton$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.